Cargando…

Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS)

BACKGROUND: Biomarker-based analyses are commonly reported in observational epidemiological studies; however currently there are no specific study quality assessment tools to assist evaluation of conducted research. Accounting for study design and biomarker measurement would be important for derivin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wirsching, Jan, Graßmann, Sophie, Eichelmann, Fabian, Harms, Laura Malin, Schenk, Matthew, Barth, Eva, Berndzen, Alide, Olalekan, Moses, Sarmini, Leen, Zuberer, Hedwig, Aleksandrova, Krasimira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219097/
https://www.ncbi.nlm.nih.gov/pubmed/30400827
http://dx.doi.org/10.1186/s12874-018-0583-x
_version_ 1783368585382461440
author Wirsching, Jan
Graßmann, Sophie
Eichelmann, Fabian
Harms, Laura Malin
Schenk, Matthew
Barth, Eva
Berndzen, Alide
Olalekan, Moses
Sarmini, Leen
Zuberer, Hedwig
Aleksandrova, Krasimira
author_facet Wirsching, Jan
Graßmann, Sophie
Eichelmann, Fabian
Harms, Laura Malin
Schenk, Matthew
Barth, Eva
Berndzen, Alide
Olalekan, Moses
Sarmini, Leen
Zuberer, Hedwig
Aleksandrova, Krasimira
author_sort Wirsching, Jan
collection PubMed
description BACKGROUND: Biomarker-based analyses are commonly reported in observational epidemiological studies; however currently there are no specific study quality assessment tools to assist evaluation of conducted research. Accounting for study design and biomarker measurement would be important for deriving valid conclusions when conducting systematic data evaluation. METHODS: We developed a study quality assessment tool designed specifically to assess biomarker-based cross-sectional studies (BIOCROSS) and evaluated its inter-rater reliability. The tool includes 10-items covering 5 domains: ‘Study rational’, ‘Design/Methods’, ‘Data analysis’, ‘Data interpretation’ and ‘Biomarker measurement’, aiming to assess different quality features of biomarker cross-sectional studies. To evaluate the inter-rater reliability, 30 studies were distributed among 5 raters and intraclass correlation coefficients (ICC-s) were derived from respective ratings. RESULTS: The estimated overall ICC between the 5 raters was 0.57 (95% Confidence Interval (CI): 0.38–0.74) indicating a good inter-rater reliability. The ICC-s ranged from 0.11 (95% CI: 0.01–0.27) for the domain ‘Study rational’ to 0.56 (95% CI: 0.40–0.72) for the domain ‘Data interpretation’. CONCLUSION: BIOCROSS is a new study quality assessment tool suitable for evaluation of reporting quality from cross-sectional epidemiological studies employing biomarker data. The tool proved to be reliable for use by biomedical scientists with diverse backgrounds and could facilitate comprehensive review of biomarker studies in human research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12874-018-0583-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6219097
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62190972018-11-16 Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS) Wirsching, Jan Graßmann, Sophie Eichelmann, Fabian Harms, Laura Malin Schenk, Matthew Barth, Eva Berndzen, Alide Olalekan, Moses Sarmini, Leen Zuberer, Hedwig Aleksandrova, Krasimira BMC Med Res Methodol Research Article BACKGROUND: Biomarker-based analyses are commonly reported in observational epidemiological studies; however currently there are no specific study quality assessment tools to assist evaluation of conducted research. Accounting for study design and biomarker measurement would be important for deriving valid conclusions when conducting systematic data evaluation. METHODS: We developed a study quality assessment tool designed specifically to assess biomarker-based cross-sectional studies (BIOCROSS) and evaluated its inter-rater reliability. The tool includes 10-items covering 5 domains: ‘Study rational’, ‘Design/Methods’, ‘Data analysis’, ‘Data interpretation’ and ‘Biomarker measurement’, aiming to assess different quality features of biomarker cross-sectional studies. To evaluate the inter-rater reliability, 30 studies were distributed among 5 raters and intraclass correlation coefficients (ICC-s) were derived from respective ratings. RESULTS: The estimated overall ICC between the 5 raters was 0.57 (95% Confidence Interval (CI): 0.38–0.74) indicating a good inter-rater reliability. The ICC-s ranged from 0.11 (95% CI: 0.01–0.27) for the domain ‘Study rational’ to 0.56 (95% CI: 0.40–0.72) for the domain ‘Data interpretation’. CONCLUSION: BIOCROSS is a new study quality assessment tool suitable for evaluation of reporting quality from cross-sectional epidemiological studies employing biomarker data. The tool proved to be reliable for use by biomedical scientists with diverse backgrounds and could facilitate comprehensive review of biomarker studies in human research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12874-018-0583-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-06 /pmc/articles/PMC6219097/ /pubmed/30400827 http://dx.doi.org/10.1186/s12874-018-0583-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wirsching, Jan
Graßmann, Sophie
Eichelmann, Fabian
Harms, Laura Malin
Schenk, Matthew
Barth, Eva
Berndzen, Alide
Olalekan, Moses
Sarmini, Leen
Zuberer, Hedwig
Aleksandrova, Krasimira
Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS)
title Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS)
title_full Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS)
title_fullStr Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS)
title_full_unstemmed Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS)
title_short Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS)
title_sort development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (biocross)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219097/
https://www.ncbi.nlm.nih.gov/pubmed/30400827
http://dx.doi.org/10.1186/s12874-018-0583-x
work_keys_str_mv AT wirschingjan developmentandreliabilityassessmentofanewqualityappraisaltoolforcrosssectionalstudiesusingbiomarkerdatabiocross
AT graßmannsophie developmentandreliabilityassessmentofanewqualityappraisaltoolforcrosssectionalstudiesusingbiomarkerdatabiocross
AT eichelmannfabian developmentandreliabilityassessmentofanewqualityappraisaltoolforcrosssectionalstudiesusingbiomarkerdatabiocross
AT harmslauramalin developmentandreliabilityassessmentofanewqualityappraisaltoolforcrosssectionalstudiesusingbiomarkerdatabiocross
AT schenkmatthew developmentandreliabilityassessmentofanewqualityappraisaltoolforcrosssectionalstudiesusingbiomarkerdatabiocross
AT bartheva developmentandreliabilityassessmentofanewqualityappraisaltoolforcrosssectionalstudiesusingbiomarkerdatabiocross
AT berndzenalide developmentandreliabilityassessmentofanewqualityappraisaltoolforcrosssectionalstudiesusingbiomarkerdatabiocross
AT olalekanmoses developmentandreliabilityassessmentofanewqualityappraisaltoolforcrosssectionalstudiesusingbiomarkerdatabiocross
AT sarminileen developmentandreliabilityassessmentofanewqualityappraisaltoolforcrosssectionalstudiesusingbiomarkerdatabiocross
AT zubererhedwig developmentandreliabilityassessmentofanewqualityappraisaltoolforcrosssectionalstudiesusingbiomarkerdatabiocross
AT aleksandrovakrasimira developmentandreliabilityassessmentofanewqualityappraisaltoolforcrosssectionalstudiesusingbiomarkerdatabiocross